BMO
Beck Mack & Oliver Portfolio holdings
AUM
$5.24B
This Quarter Return
-21.34%
1 Year Return
+18.97%
3 Year Return
+82.59%
5 Year Return
+169.99%
10 Year Return
+321.3%
AUM
$2.25B
AUM Growth
+$2.25B
(-26%)
Cap. Flow
-$35.9M
Cap. Flow
% of AUM
-1.6%
Top 10 Holdings %
Top 10 Hldgs %
44.94%
Holding
222
New
5
Increased
26
Reduced
98
Closed
34
Top Buys
1 |
Teva Pharmaceuticals
TEVA
|
$9.04M |
2 |
RadNet
RDNT
|
$8.75M |
3 |
Enterprise Products Partners
EPD
|
$7.04M |
4 |
Charles Schwab
SCHW
|
$6.53M |
5 |
Labcorp
LH
|
$4.12M |
Top Sells
1 |
Gilead Sciences
GILD
|
$18M |
2 |
Wabtec
WAB
|
$10M |
3 |
AB InBev
BUD
|
$7.69M |
4 |
Baxter International
BAX
|
$6.2M |
5 |
US Bancorp
USB
|
$5.65M |
Sector Composition
1 | Financials | 33.61% |
2 | Healthcare | 17.72% |
3 | Technology | 15.08% |
4 | Communication Services | 9.83% |
5 | Industrials | 8.31% |